Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.3385 | 1 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0084 | 0.5476 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.3385 | 1 |
Giardia lamblia | NADPH oxidoreductase, putative | 0.0084 | 0.5476 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0084 | 0.5476 | 1 |
Echinococcus granulosus | Mitotic checkpoint protein PRCC C terminal | 0.0126 | 0.9121 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0084 | 0.5476 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0084 | 0.5476 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0126 | 0.9121 | 0.8937 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0084 | 0.5476 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0084 | 0.5476 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0084 | 0.5476 | 1 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0084 | 0.5476 | 1 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0084 | 0.5476 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0084 | 0.5476 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0063 | 0.3652 | 0.6669 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.3385 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0084 | 0.5476 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.3385 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0084 | 0.5476 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0084 | 0.5476 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0084 | 0.5476 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0084 | 0.5476 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0084 | 0.5476 | 1 |
Giardia lamblia | NADPH oxidoreductase, putative | 0.0084 | 0.5476 | 0.5 |
Giardia lamblia | NADPH oxidoreductase, putative | 0.0084 | 0.5476 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 7.0795 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 10.4179 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.